Peter K. Linden

3.7k total citations · 1 hit paper
34 papers, 2.8k citations indexed

About

Peter K. Linden is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Peter K. Linden has authored 34 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 14 papers in Epidemiology and 14 papers in Clinical Biochemistry. Recurrent topics in Peter K. Linden's work include Bacterial Identification and Susceptibility Testing (14 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Antifungal resistance and susceptibility (7 papers). Peter K. Linden is often cited by papers focused on Bacterial Identification and Susceptibility Testing (14 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Antifungal resistance and susceptibility (7 papers). Peter K. Linden collaborates with scholars based in United States, Australia and Hungary. Peter K. Linden's co-authors include Ali Hassoun, Bruce Friedman, David L. Paterson, Shimon Kusne, A. William Pasculle, Robert C. Moellering, Dion Kramer, Kim C. Coley, Paulo Fontes and Marcus Zervos and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

Peter K. Linden

34 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment

2017 452 citations Peter K. Linden et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter K. Linden United States	25	1.4k	932	869	615	462	34	2.8k
Mondell L. Beach United States	21	1.3k 0.9×	996 1.1×	750 0.9×	788 1.3×	652 1.4×	31	2.8k
Mandy Wootton United Kingdom	28	1.2k 0.9×	940 1.0×	986 1.1×	688 1.1×	634 1.4×	92	2.8k
Laurence Armand-Lefèvre France	29	1.2k 0.8×	650 0.7×	898 1.0×	1.2k 1.9×	688 1.5×	112	3.0k
René Courcol France	31	854 0.6×	543 0.6×	976 1.1×	443 0.7×	489 1.1×	116	2.5k
D. Milatović Germany	23	1.1k 0.8×	588 0.6×	722 0.8×	721 1.2×	470 1.0×	59	2.2k
J. Caillon France	32	958 0.7×	451 0.5×	1.0k 1.2×	759 1.2×	608 1.3×	192	3.4k
Paul Lephart United States	28	947 0.7×	551 0.6×	937 1.1×	941 1.5×	425 0.9×	75	2.4k
Thean Yen Tan Singapore	32	835 0.6×	629 0.7×	832 1.0×	1.3k 2.1×	507 1.1×	104	2.8k
Eduardo Rodríguez-Noriega Mexico	29	991 0.7×	417 0.4×	767 0.9×	753 1.2×	604 1.3×	110	2.3k
J. A. A. Hoogkamp‐Korstanje Netherlands	34	1.5k 1.1×	331 0.4×	1.2k 1.4×	448 0.7×	413 0.9×	111	3.4k

Countries citing papers authored by Peter K. Linden

Since Specialization

Citations

This map shows the geographic impact of Peter K. Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Linden more than expected).

Fields of papers citing papers by Peter K. Linden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K. Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Linden. The network helps show where Peter K. Linden may publish in the future.

Co-authorship network of co-authors of Peter K. Linden

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. Linden. A scholar is included among the top collaborators of Peter K. Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. Linden. Peter K. Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Linden, Peter K.. (2009). History of Solid Organ Transplantation and Organ Donation. Critical Care Clinics. 25(1). 165–184. 116 indexed citations

Linden, Peter K.. (2009). Approach to the Immunocompromised Host with Infection in the Intensive Care Unit. Infectious Disease Clinics of North America. 23(3). 535–556. 26 indexed citations

Aggarwal, S, et al.. (2008). Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial doppler ultrasonography. Liver Transplantation. 14(7). 1048–1057. 74 indexed citations

Kollef, Marin H., Lena M. Napolitano, Joseph S. Solomkin, et al.. (2008). Health Care–Associated Infection (HAI): A Critical Appraisal of the Emerging Threat—Proceedings of the HAI Summit. Clinical Infectious Diseases. 47(s2). S55–S99. 50 indexed citations

Fujitani, Shigeki, Brian A. Potoski, Blair Capitano, et al.. (2007). Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical β-lactam antibiotic therapy be improved?. International Journal of Antimicrobial Agents. 30(5). 458–462. 29 indexed citations

Linden, Peter K. & David L. Paterson. (2006). Parenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia. Clinical Infectious Diseases. 43(Supplement_2). S89–S94. 92 indexed citations

Potoski, Brian A., Jennifer Adams, Lloyd Clarke, et al.. (2006). Epidemiological Profile of Linezolid‐Resistant Coagulase‐Negative Staphylococci. Clinical Infectious Diseases. 43(2). 165–171. 79 indexed citations

Murugan, Raghavan & Peter K. Linden. (2004). Newer Treatment Options for Skin and Soft Tissue Infections. Drugs. 64(15). 1621–1642. 66 indexed citations

Finberg, Robert W., Robert C. Moellering, Francis P. Tally, et al.. (2004). The Importance of Bactericidal Drugs: Future Directions in Infectious Disease. Clinical Infectious Diseases. 39(9). 1314–1320. 151 indexed citations

10.

Linden, Peter K., Shimon Kusne, Kim C. Coley, et al.. (2003). Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa. Clinical Infectious Diseases. 37(11). e154–e160. 217 indexed citations

11.

Clermont, Gilles, Derek C. Angus, Kenneth G. Kalassian, et al.. (2003). Reassessing the value of short-term mortality in sepsis: Comparing conventional approaches to modeling. Critical Care Medicine. 31(11). 2627–2633. 16 indexed citations

12.

Linden, Peter K.. (2003). Amphotericin B lipid complex for the treatment of invasive fungal infections. Expert Opinion on Pharmacotherapy. 4(11). 2099–2110. 3 indexed citations

13.

Linden, Peter K.. (2002). Treatment Options for Vancomycin- Resistant Enterococcal Infections. Drugs. 62(3). 425–441. 122 indexed citations

14.

Linden, Peter K., et al.. (2001). Hyperbilirubinemia during Quinupristin‐Dalfopristin Therapy in Liver Transplant Recipients: Correlation with Available Liver Biopsy Results. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(6). 661–668. 6 indexed citations

15.

Linden, Peter K., Robert C. Moellering, C A Wood, et al.. (2001). Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/Dalfopristin. Clinical Infectious Diseases. 33(11). 1816–1823. 69 indexed citations

16.

Moellering, Robert C., Peter K. Linden, J. F. Reinhardt, et al.. (1999). The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 44(2). 251–261. 166 indexed citations

17.

Vinayek, Rakesh, et al.. (1998). Disseminated histoplasmosis in a patient after orthotopic liver transplantation. Clinical Transplantation. 12(3). 274–277. 9 indexed citations

18.

Linden, Peter K.. (1998). Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance. The American Journal of Medicine. 104(5). 24S–33S. 52 indexed citations

19.

Linden, Peter K., A. William Pasculle, D. G. McDevitt, & Dion Kramer. (1997). Effect of quinupristin/dalfopristin on the outcome of vancomycin- resistant Enterococcus faecium bacteraemia: comparison with a control cohort. Journal of Antimicrobial Chemotherapy. 39(suppl 1). 145–151. 68 indexed citations

20.

Linden, Peter K., A. William Pasculle, Dion Kramer, et al.. (1996). Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus faecium or Vancomycin-Susceptible E. faecium. Clinical Infectious Diseases. 22(4). 663–670. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact